MX2010003114A - Vacuna para tratamiento de osteoartritis. - Google Patents

Vacuna para tratamiento de osteoartritis.

Info

Publication number
MX2010003114A
MX2010003114A MX2010003114A MX2010003114A MX2010003114A MX 2010003114 A MX2010003114 A MX 2010003114A MX 2010003114 A MX2010003114 A MX 2010003114A MX 2010003114 A MX2010003114 A MX 2010003114A MX 2010003114 A MX2010003114 A MX 2010003114A
Authority
MX
Mexico
Prior art keywords
vaccine
vertebrate
osteoarthritis
treatment
beta
Prior art date
Application number
MX2010003114A
Other languages
English (en)
Inventor
Wilhelmus Gerardus Johannes Degen
Virgil Elisabeth Joseph Caspar Schijns
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2010003114A publication Critical patent/MX2010003114A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención pertenece a una vacuna para el tratamiento de la osteoartritis en un vertebrado, que comprende citocinas IL-1ß y opcionalmente TNF-a o derivados de las mismas, y en asociación con IL-1ß y opcionalmente TNF-a o derivados de las mismas, una parte que no sea propia con respecto al vertebrado tal que la vacuna provoque una inmunorespuesta en el vertebrado contra moléculas propias de IL-1ß y TNF-a del vertebrado.
MX2010003114A 2007-09-25 2008-09-24 Vacuna para tratamiento de osteoartritis. MX2010003114A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US97490307P 2007-09-25 2007-09-25
EP07117111 2007-09-25
US1487707P 2007-12-19 2007-12-19
EP07150183 2007-12-20
PCT/EP2008/062722 WO2009040361A1 (en) 2007-09-25 2008-09-24 Vaccine for the treatment of osteoarthritis

Publications (1)

Publication Number Publication Date
MX2010003114A true MX2010003114A (es) 2010-06-23

Family

ID=40044114

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003114A MX2010003114A (es) 2007-09-25 2008-09-24 Vacuna para tratamiento de osteoartritis.

Country Status (12)

Country Link
US (1) US20110027222A1 (es)
EP (1) EP2195016A1 (es)
JP (1) JP2010540487A (es)
KR (1) KR20100084623A (es)
CN (1) CN101808656A (es)
AU (1) AU2008303582A1 (es)
BR (1) BRPI0817705A2 (es)
CA (1) CA2698920A1 (es)
CO (1) CO6270236A2 (es)
MX (1) MX2010003114A (es)
WO (1) WO2009040361A1 (es)
ZA (1) ZA201001594B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1178955C (zh) * 1997-04-15 2004-12-08 法默卡有限公司 经修饰的TNFα分子和编码该TNFα分子的DNA以及含有该TNFα分子和该DNA的疫苗
NZ563580A (en) * 2005-06-07 2010-09-30 Esbatech An Alcon Biomedical R Stable and soluble antibodies inhibiting TNFaplha
CN101267834B (zh) * 2005-09-28 2013-06-05 赛托斯生物技术公司 白介素-1偶联物及其用途

Also Published As

Publication number Publication date
AU2008303582A1 (en) 2009-04-02
KR20100084623A (ko) 2010-07-27
US20110027222A1 (en) 2011-02-03
ZA201001594B (en) 2011-05-25
CA2698920A1 (en) 2009-04-02
EP2195016A1 (en) 2010-06-16
CN101808656A (zh) 2010-08-18
BRPI0817705A2 (pt) 2015-03-31
WO2009040361A1 (en) 2009-04-02
CO6270236A2 (es) 2011-04-20
JP2010540487A (ja) 2010-12-24

Similar Documents

Publication Publication Date Title
MY170607A (en) Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
EA201170832A1 (ru) Пуриновые соединения
WO2009056550A3 (en) Bupropion hydrobromide and therapeutic applications
CL2012001405A1 (es) Compuestos derivados de espiroindolinona-pirrolidinas; proceso de obtención; composicion farmaceutica; y uso en el tratamiento o profilaxis del cancer.
MX2011007930A (es) Conjugados de insulina cristalina.
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
EA201171367A1 (ru) Винилиндазолильные соединения
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
BRPI1013698A2 (pt) métodos para tratamento com o uso de terapia de combinação
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
MA32544B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
MX2010002736A (es) Derivados de 1-amino-alquilciclohexano para el tratamiento de tinnitus coclear.
MX2010000098A (es) Derivados de guanina policiclicos y sus metodos de uso.
BR112012026707A2 (pt) uso de um anticorpo anti-cd20 afucosilado, composição que compreende um anticorpo anti-cd20 afucosilado e método de tratamento de pacientes que sofrem de câncer por meio da administração de um anticorpo anti-cd20 afucosilado
BR112013002441A2 (pt) uso de um anticorpo anti-cd20 afucosilado, composição e método de tratamento de paciente que sofre de câncer
EA200801676A1 (ru) Комбинация производных триазина и сенсибилизаторов инсулина
GEP20166489B (en) 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
SMT201500032B (it) Combinazione di insulina con derivati di triazina e suo uso per il trattamento del diabete
AU2010286532A8 (en) Methods of treatment using anti-oxidized LDL antibodies
GB0710536D0 (en) Plant extract and its therapeutic use
ZA201007091B (en) Vaccine compositions for the treatment of dengue fever and uses thereof
CL2012001010A1 (es) Compuesto 4-[etil(dimetil)amonio]butanoato; procesos de preparacion de este compuesto; y su uso en el tratamiento de enfermedades cardiovasculares.
CL2012001606A1 (es) Compuestos derivados de tiazoles bicíclicos como moduladores alostéricos de receptores mglur5; composición farmacéutica que los comprende; procedimiento de preparación de la composición farmacéutica; combinación farmacéutica; y uso del compuesto en la prevención, tratamiento o profilaxis de trastornos neurológicos o psiquiátricos.
BRPI0909096A2 (pt) uso de conjugados de interleicna-1 no tratamento de diabetes
DK2268624T3 (da) Arylpyrazinon-derivater som insulin-sekretions-stimulatorer, fremgangsmåde til opnåelse deraf og anvendelse deraf til behandlingen af diabetes

Legal Events

Date Code Title Description
FA Abandonment or withdrawal